Idelalisib for the treatment of indolent non-Hodgkin's lymphoma. (Q38195233)
Jump to navigation
Jump to search
scientific article published on February 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Idelalisib for the treatment of indolent non-Hodgkin's lymphoma. |
scientific article published on February 2014 |
Statements
Idelalisib for the treatment of indolent non-Hodgkin's lymphoma (English)